These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9662127)

  • 21. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
    Tai H; Miyaura C; Pilbeam CC; Tamura T; Ohsugi Y; Koishihara Y; Kubodera N; Kawaguchi H; Raisz LG; Suda T
    Endocrinology; 1997 Jun; 138(6):2372-9. PubMed ID: 9165025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Megakaryocyte-mediated inhibition of osteoclast development.
    Kacena MA; Nelson T; Clough ME; Lee SK; Lorenzo JA; Gundberg CM; Horowitz MC
    Bone; 2006 Nov; 39(5):991-999. PubMed ID: 16782418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A third-generation bisphosphonate, YM175, inhibits osteoclast formation in murine cocultures by inhibiting proliferation of precursor cells via supporting cell-dependent mechanisms.
    Nishikawa M; Yamamoto M; Murakami T; Akatsu T; Kugai N; Nagata N
    J Bone Miner Res; 1998 Jun; 13(6):986-95. PubMed ID: 9626630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of osteoclast-like cell formation by sodium salicylate and indomethacin in mouse bone marrow culture.
    Soekanto A
    Jpn J Pharmacol; 1994 May; 65(1):27-34. PubMed ID: 8089927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS; Flanagan AM
    Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4.
    Ueda N; Koide M; Ohguchi M; Ishihara Y; Noguchi T; Okahashi N; Nishihara T
    J Periodontal Res; 1998 Nov; 33(8):509-16. PubMed ID: 9879525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 strongly inhibits human osteoclast formation.
    Take I; Kobayashi Y; Yamamoto Y; Tsuboi H; Ochi T; Uematsu S; Okafuji N; Kurihara S; Udagawa N; Takahashi N
    Endocrinology; 2005 Dec; 146(12):5204-14. PubMed ID: 16150915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of triiodothyronine with 1alpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures.
    Schiller C; Gruber R; Ho GM; Redlich K; Gober HJ; Katzgraber F; Willheim M; Hoffmann O; Pietschmann P; Peterlik M
    Bone; 1998 Apr; 22(4):341-6. PubMed ID: 9556133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.
    Udagawa N; Takahashi N; Akatsu T; Sasaki T; Yamaguchi A; Kodama H; Martin TJ; Suda T
    Endocrinology; 1989 Oct; 125(4):1805-13. PubMed ID: 2676473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
    Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
    J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study.
    Galvin RJ; Bryan P; Venugopalan M; Smith DP; Thomas JE
    Bone; 1998 Sep; 23(3):233-40. PubMed ID: 9737345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
    Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental study on substance P in the regulation of degranulation of cultured murine mast cells].
    Cheng FL; Li QT; Zhao CQ; An YF; Qi XP
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Sep; 51(9):675-680. PubMed ID: 27666706
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time.
    Tsurukai T; Takahashi N; Jimi E; Nakamura I; Udagawa N; Nogimori K; Tamura M; Suda T
    J Cell Physiol; 1998 Oct; 177(1):26-35. PubMed ID: 9731742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture.
    Miyamoto K; Suzuki H; Yamamoto S; Saitoh Y; Ochiai E; Moritani S; Yokogawa K; Waki Y; Kasugai S; Sawanishi H; Yamagami H
    J Bone Miner Res; 2003 Aug; 18(8):1471-7. PubMed ID: 12929936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
    Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
    Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis.
    Ha H; Lee JH; Kim HN; Kim HM; Kwak HB; Lee S; Kim HH; Lee ZH
    J Immunol; 2006 Jan; 176(1):111-7. PubMed ID: 16365401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.